Learn Your Way to A Healthier Life

iHealth Labs has opened a new office in Sacramento at 8950 Cal Center Drive to accommodate its rapidly growing Unified Care program. With its contributions as a pivotal COVID-19 home test provider and a decade-long dedication to reimagining chronic disease care, the company is poised to amplify its impact for population health with the expansion of the Unified Care program in Northern California, especially the Greater Sacramento Area.   

iHealth's manufacturing facility for COVID-19 tests in Irwindale, CA has manufactured over 70 million test kits to-date. The iHealth team has made a substantial investment to establish this US-based production facility for COVID-19 at-home tests. The facility, which opened in August 2022, spans 57,800 square feet and boasts 32 production lines. iHealth has created hundreds of local jobs and has production capacity of up to one million tests per day. 

iHealth launched the CheckMeSafe Home Collection kit, its first in the STD OTC test category, in response to the growing STD crisis in the US. The CDC has called for more groups from local, healthcare industry and public health sectors to contribute to STI prevention and innovation efforts. The FDA-approved CheckMeSafe Home Collection kit delivers reliable results of up to 99.9% sensitivity for HIV and 99.5% for syphilis. 

iHealth Labs, Inc., one of the major suppliers of at-home COVID tests in the U.S. market, is donating 1 million at-home COVID tests to the State of California. This donation will provide California's residents with much-needed support as another surge in coronavirus infections in the state has led to high demand for early detection.

iHealth Labs, Inc. made its Super Bowl debut with in-stadium advertising highlighting its commitment to bring at-home COVID-19 tests to more people as quickly as possible. iHealth's Super Bowl advertising featured LED ribbon takeovers and branded openings on the stadium's video board that ran during the breaks at the end of the first and third quarters on Sunday, Feb. 13 at SoFi Stadium.

iHealth has been continuously monitoring the COVID-19 variants so the iHealth COVID-19 Antigen Rapid Test is ready to address any significant changes in the epidemic. We are confident that our rapid antigen test continues to detect COVID-19 infection, including infection with the Omicron variant.

iHealth Labs, Inc. announced today the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for over the counter (OTC) sale of iHealth's COVID-19 Antigen Rapid Test. This self-test is suitable for individual or group testing anytime, anywhere, and delivers test results in 15 minutes at home. It is authorized and available for purchase at iHealthLabs.com in packages of two test kits.